Emerg Infect Dis by Mokrousov, Igor et al.
of 1/2, 5/6, 943, and 944 but PCR negative for the 1/6 am-
plicon (Figure, panels B–D). The only minor difference 
between strains Stre15001 and 05ZYH33 lay in the 3/4 
amplicon (Figure, panel C). Clearly the 3/4 DNA frag-
ment is present in the 89K PAI from strain 05ZYH33 but 
not in the counterpart of the strain Stre15001 (Figure, 
panel C); that is, strain Stre15001 carries a variant of 89K 
PAI lacking (at least part of, if not all) the 3/4 DNA frag-
ment. In terms of 89K PAI (and pulsed-field gel electro-
phoresis/Sao protein), we propose that a heterogeneous 
SS2 population is circulating in China. Also, we observe 
that the differentiation of bacterial virulence is related to 
the clinical strains using the infection model of Balb/c 
mice (online Technical Appendix Figure 5).
In summary, the loss of 89K PAI might highlight the 
emergence of an epidemic SS2 population. This population 
appears to have genetic heterogeneity that is undergoing 
evolution in an adaption to some selection pressure from 
the environment, host restriction, or both.
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To the Editor: Next-generation sequencing (NGS) 
technology is becoming more affordable and is increasing-
ly being widely used for high-resolution molecular epide-
miology of tuberculosis. Using an example of the emerging 
multidrug-resistant strain of Mycobacterium tuberculosis, 
we showed the value of informed understanding when in 
silico prediction from NGS data achieved with available 
bioinformatics tools is placed within the context of the ex-
isting genotyping framework.
Spoligotyping is a classical method of M. tuberculo-
sis genotyping, and the SITVIT_WEB database contains 
data on 7,105 spoligotype patterns of 58,180 isolates from 
153 countries (http://www.pasteur-guadeloupe.fr:8081/
SITVIT_ONLINE). Spoligotyping targets a variation of 
the DR/CRISPR locus, whose evolution in M. tuberculosis 
occurs through deletion of single or multiple spacers. By 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 22, No. 6, June 2016 1127
LETTERS
virtue of the orientation of the associated cas genes, the lo-
cus is situated on the minus strand, whereas its spacers are 
numbered within the locus, not the genome. Spoligotype 
international type (SIT) 266 (Figure, panel A) is an epide-
miologically significant genotype. It constitutes a substan-
tial proportion of the population structure of M. tuberculo-
sis in Belarus, a post-Soviet state in Eastern Europe (1,2), 
and has been described sporadically in the neighboring 
provinces in northwestern and central Russia (2–5) and in 
Latvia (6). More important, it is multidrug resistant (MDR) 
(and most likely extensively drug resistant). In a recent Be-
larus study, SIT266 was found in 25 of 163 strains; all 25 
were MDR (1). This situation contrasts clearly with its ap-
parently parental type SIT264, which differs from SIT266 
in a single spacer 8 (Figure, panel A). SIT264 is more wide-
spread across Eastern Europe but at very low prevalence 
and is not associated with multidrug resistance (3,6,7). On 
the basis of 24 mycobacterial interspersed repetitive unit 
variable number tandem repeats clustering and robust phy-
logenetic single-nucleotide polymorphisms, SIT264 and 
SIT266 isolates are assigned to the Latin American–Medi-
terranean lineage of M. tuberculosis (2).
We recovered 2 MDR M. tuberculosis isolates of 
SIT266 from pulmonary tuberculosis patients from north-
western Russia in 2014. Bacterial DNA was subjected to 
macroarray-based spoligotyping (8) and whole-genome 
sequencing on the MiSeq platform (Illumina, San Diego, 
CA, USA). M. tuberculosis NGS data were deposited in the 
National Center for Biotechnology Information Sequence 
Read Archive (project no. PRJNA305488).
The short sequencing reads were subjected to analy-
sis by using the SpoTyping program (https://github.com/
xiaeryu/SpoTyping) (9) and the TGS-TB online tool 
(https://gph.niid.go.jp/tgs-tb/) (10) to deduce their spoli-
goprofile. We used the TGS-TB tool to map the IS6110 
insertion sites and detect drug resistance mutations. The 
reads also were mapped to the genome of reference strain 
H37Rv (GenBank accession no. NC_00962.3) by using 
the Geneious 9.0 package (Biomatters Ltd, Auckland, 
New Zealand). We obtained 1,294,895 and 816,693 paired 
reads for strains 4542 and 8279, respectively, and mapped 
them to the reference. Mean read length was 300 bp, and 
the average genome coverage was 72.
Strains 4542 and 8279 were phenotypically MDR and 
harbored mutations associated with resistance to all 5 first 
line-drugs. The macroarray hybridization spoligotyping as-
signed both strains to spoligotype SIT266. However, by in 
silico typing, their spoligotype was predicted to be SIT264 
(Figure, panel A). To reconcile these findings, we hypoth-
esized that this discrepancy resulted from an IS6110 asym-
metrically inserted in the direct repeat unit adjacent to the 
spacer 8 in a SIT266 isolate. This insertion would disrupt 
a target sequence for biotin-labeled DRa primer, thus pre-
venting spacer 8 from amplification. Indeed, in both SIT266 
isolates, the in silico analysis identified a forward IS6110 
insertion that was mapped to position 3122916 in H37Rv 
genome (online Technical Appendix Figure, http://wwwnc.
cdc.gov/EID/article/22/6/15-2051-Techapp1.pdf). This lo-
cation correlates with the location of spacer 8 in this same 
genome from positions 3122954 to 3122918. Thus, IS6110 
precedes spacer 8 in the genome of isolate with spoligotype 
SIT266, or follows it, within the DR locus (Figure, panel B; 
online Technical Appendix Figure).
An immediate excellent contribution of NGS with regard 
to tuberculosis treatment and control is its capacity to rapidly 
screen for multiple gene targets linked to the development 
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Figure. A) Spoligotyping 
hybridization profiles of H37Rv 
and BCG reference strains, 
Mycobacterium tuberculosis 
SIT266 (2 strains in this 
study) and SIT264 (previously 
published strain in [3]). SIT, 
spoligotype international type, 
designated according to SITVIT_
WEB database (http://www.
pasteur-guadeloupe.fr:8081/
SITVIT_ONLINE). B) Schematic 
view of the DR/CRISPR locus 
(region of spacers 7–9) in 
spoligotypes SIT264 and SIT266 
and reference strain H37Rv, 
inferred from next-generation 
sequencing data. Reverse DRa 
primer is biotin-labeled. IS6110 
is not to scale.
of drug resistance. However, knowledge of strain genotype 
is no less clinically and epidemiologically relevant. A super-
spreading strain might be marked with other pathobiologi-
cally important features. In the case presented here (indeed 
emerging and MDR), the NGS-based in silico spoligotyping 
would confuse the MDR/extensively drug resistant SIT266 
with “less dangerous” SIT264. To be precise, the revealed 
discrepancy is not inherent to the NGS technology itself. Al-
though the general limitation of the use of short sequencing 
reads to infer repetitive genome regions is known, it did not 
pose a problem in our study. However, both bioinformatics 
tools predicted the spoligoprofile solely from the presence or 
absence of spacer sequences and did not take into account 
a “hiding” effect exerted by a putative IS6110 insertion on 
adjacent spacer under classical spoligotyping.
In conclusion, we suggest that an accurate NGS-
based prediction requires an integrative approach to all 
relevant information obtained by in silico analysis of a 
given genome locus. In particular, not only presence of 
CRISPR spacers but also presence and location of poten-
tially interfering IS6110 insertion(s) should be considered 
for correct NGS-based assignment to internationally rec-
ognized spoligotypes.
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To the Editor: Accumulating evidence indicates that 
dromedaries (Camelus dromedarius) are a reservoir for 
zoonotic transmission of Middle East respiratory syndrome 
coronavirus (MERS-CoV). Although numerous studies 
have looked at other livestock in the Middle East region, 
evidence for MERS-CoV infection has only been found 
in dromedaries (1). Extensive and continuous circulation 
of MERS-CoV occurs in the Al Shahaniya region of Qa-
tar, most likely because of the presence of an international 
camel racing track and numerous barns holding camels 
(2,3). In April 2015, we investigated the MERS-CoV infec-
tion status of 15 healthy alpacas (Vicugna pacos) in a herd 
of 20 animals and 10 healthy dromedaries in a herd of 25 
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